lysophosphatidic acid has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, R; Jiang, H; Liu, S; Min, L; Ning, T; Wang, T; Wang, X; Xu, J; Zhang, Q; Zhang, S; Zhu, S | 1 |
1 other study(ies) available for lysophosphatidic acid and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression.
Topics: Animals; Cell Line, Tumor; Cell Lineage; Cell Movement; Cell Proliferation; Disease Progression; Esophageal Squamous Cell Carcinoma; Heterografts; Humans; Lysophospholipids; Mice; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid | 2021 |